The government plans to help boost the local small-molecule drug CDMO industry by cooperating with firms to jointly develop key technology platforms, the Ministry of Economic Affairs (MOEA) said yesterday.
CDMO refers to a contract development and manufacturing organization, which provides essential services to both pharmaceutical and biotech companies with lower-cost, time-saving drug research, manufacturing and testing processes.
The key technology platforms, which would have a high entry threshold, include active pharmaceutical ingredient (API) intermediates, continuous manufacturing processes as well as special delivery solutions and dosage forms for small molecules, the ministry said in a statement.
Photo courtesy of Ministry of Economic Affairs
The ministry said it would also assist firms in conducting carbon emission investigations, enhance their engagement in international markets and simplify administrative procedures to facilitate global CDMO business opportunities.
The ministry’s remarks came after it held a meeting on Wednesday with representatives from domestic API makers, pharmaceutical formulation providers and
medical associations, as well as several health and welfare officials and researchers to discuss how to promote Taiwan’s small molecule CDMO industry.
Small molecule drugs are synthesized organic compounds with low molecular weights that allow them to penetrate cells easily and target important proteins.
The production value of small molecule drugs accounts for about 70 percent of Taiwan’s total pharmaceutical output of NT$108.9 billion (US$3.5 billion), making it a key part of the nation’s pharmaceutical industry, the ministry said.
However, many local small molecule drug manufacturers are less focused on advanced technology and lack connections with international markets, the ministry said, adding that it aims to help fims upgrade and build international links.
Rising demand for small molecule drugs is expected to create business opportunities for CDMOs. A Future Market Insights report issued in November last year said that the global small molecule CDMO market is projected to be valued at about US$124.53 billion in 2034, as the market is estimated to grow at a compound annual growth rate of 5.24 percent over the next 10 years.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said that its investment plan in Arizona is going according to schedule, following a local media report claiming that the company is planning to break ground on its third wafer fab in the US in June. In a statement, TSMC said it does not comment on market speculation, but that its investments in Arizona are proceeding well. TSMC is investing more than US$65 billion in Arizona to build three advanced wafer fabs. The first one has started production using the 4-nanometer (nm) process, while the second one would start mass production using the
When an apartment comes up for rent in Germany’s big cities, hundreds of prospective tenants often queue down the street to view it, but the acute shortage of affordable housing is getting scant attention ahead of today’s snap general election. “Housing is one of the main problems for people, but nobody talks about it, nobody takes it seriously,” said Andreas Ibel, president of Build Europe, an association representing housing developers. Migration and the sluggish economy top the list of voters’ concerns, but analysts say housing policy fails to break through as returns on investment take time to register, making the
‘SILVER LINING’: Although the news caused TSMC to fall on the local market, an analyst said that as tariffs are not set to go into effect until April, there is still time for negotiations US President Donald Trump on Tuesday said that he would likely impose tariffs on semiconductor, automobile and pharmaceutical imports of about 25 percent, with an announcement coming as soon as April 2 in a move that would represent a dramatic widening of the US leader’s trade war. “I probably will tell you that on April 2, but it’ll be in the neighborhood of 25 percent,” Trump told reporters at his Mar-a-Lago club when asked about his plan for auto tariffs. Asked about similar levies on pharmaceutical drugs and semiconductors, the president said that “it’ll be 25 percent and higher, and it’ll
CHIP BOOM: Revenue for the semiconductor industry is set to reach US$1 trillion by 2032, opening up opportunities for the chip pacakging and testing company, it said ASE Technology Holding Co (日月光投控), the world’s largest provider of outsourced semiconductor assembly and test (OSAT) services, yesterday launched a new advanced manufacturing facility in Penang, Malaysia, aiming to meet growing demand for emerging technologies such as generative artificial intelligence (AI) applications. The US$300 million facility is a critical step in expanding ASE’s global footprint, offering an alternative for customers from the US, Europe, Japan, South Korea and China to assemble and test chips outside of Taiwan amid efforts to diversify supply chains. The plant, the company’s fifth in Malaysia, is part of a strategic expansion plan that would more than triple
RSS